300039.SZ · 上海凯宝
China A-shares · RS rating 70 · As of 2026-10-14
| Price | 5.12 CNY |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 70 / 51 / 86 / 47 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 38 / 23 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -36.6% |
| Distance from 52-week high | +23.1% |
| Market cap (USD) | $843.2M |